Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that 5% minoxidil topical foam was effective in stabilizing hair density and scalp coverage in men with moderate androgenetic alopecia over 104 weeks, with good safety and tolerability.

This study reported that using 5% minoxidil topical foam twice daily improved hair density and width in both the frontotemporal and vertex regions of men with moderate androgenetic alopecia.

This review discusses the surgical methods of hair restoration, highlighting the density benefits of scalp reduction and rotation, but reports no new clinical findings.

This review discusses unique anatomical features and management strategies for crown alopecia but reports no new clinical findings, focusing instead on surgical techniques for natural-looking results and optimal density.

In this case report, a patient with progressive hair loss linked to hair-pulling during emotional stress showed marked improvement in hair density after treatment with oral N-acetylcysteine and topical minoxidil, along with cessation of the hair-pulling behavior.

This pilot study found that using polydioxanone monofilament threads for scalp stringing resulted in significant hair regrowth and increased hair density in male patients with vertex androgenetic alopecia (crown baldness) over six months, showing favorable and promising outcomes.

A new reliable scale improves accuracy in measuring hair density and treatment response.

This study offers a new perspective on androgenetic alopecia, suggesting that hair loss at the vertex and frontal scalp results from mechanical and thermodynamic stress, alongside androgen activity, and proposes that reducing mechanical tension and improving local microcirculation could complement traditional treatments.

This study reports that a new multi-slit knife for hair transplant procedures reduces surgical time and increases precision by enabling quick creation of equidistant "brick-pattern" sagittal slits.

This article explores aesthetic techniques in follicular hair transplantation, emphasizing natural-looking results and plans to present a case study, but it reports no new clinical findings.

This study found that multi-hair follicles in nonbald men are primarily oriented perpendicular to the radial line from the crown whorl, suggesting perpendicular transplant grafts might mimic natural appearance.

In this study, male participants with early androgenetic alopecia experienced a significant increase in hair growth rate after applying topical lipoid cepharanthine lotion for six months.

This case report details a 28-year-old male with early-stage androgenetic alopecia who experienced significant hair density and thickness improvements following a three-month platelet-rich plasma therapy regimen, supporting its potential efficacy in similar cases.

In this case report, a 28-year-old male with androgenetic alopecia experienced significant improvement in hair density and shaft thickness after a three-month platelet-rich plasma therapy regimen, supporting existing literature on PRP's efficacy for early-to-moderate hair loss.

This study compared the diagnostic effectiveness of Folliscope and Trichoscope in 100 men with androgenetic alopecia, concluding that using both methods enhances diagnostic accuracy by providing complementary insights—Trichoscope highlights patterns while Folliscope offers objective measurements.

A woman developed rare, unexplained curly hair on her scalp and eyelashes.

Red and infrared light therapy improves hair growth in balding patients.

CRT is more effective than oral minoxidil alone for treating hair loss.

This review concluded that low-dose oral minoxidil is an effective and well-tolerated treatment for male androgenetic alopecia, with significant hair density improvements and manageable side effects.

In this randomized controlled trial, oral minoxidil at 2.5 mg daily was more effective than topical minoxidil for increasing hair thickness, counts, and density in men with androgenetic alopecia, demonstrating more significant improvements and better compliance over six months.

This study found that among various treatments for male androgenetic alopecia, dutasteride 0.5 mg/day was the most effective option overall. Additionally, among FDA-approved treatments, topical minoxidil 5% was the most effective topical therapy, and finasteride 1 mg/day was the most effective oral therapy.

This pilot study found that using skin patting and iontophoresis to deliver a 6% dutasteride gel led to significant improvements in hair density and shaft diameter in men and postmenopausal women with treatment-resistant androgenetic alopecia, with no reported adverse events.

This study found that using a specific ratio method based on the patient's scalp measurements can effectively predict the dimensions of the permanent safe zone for hair transplants, particularly in early stages of androgenetic alopecia, potentially ensuring long-lasting transplant results.

In this case report, a 41-year-old man with moderate androgenic alopecia showed an increase in hair density and improvements in hair characteristics after using Zimmer aqueous spray containing Zimmer herbal extract powder for 3 months, suggesting its potential as an alternative treatment for hair loss.

This article previews a Journal of Investigative Dermatology quiz on diagnosing male androgenetic alopecia and offers no new research results.

This study observed that Koreans generally have lower hair density, larger diameter, and slower growth rate compared to Caucasians, providing useful baseline data for studying hair diseases and treatments.

In this case study, a 37-year-old man with chronic hair loss and vertex baldness experienced significant hair regrowth, increased density, and improved appearance after receiving combined homoeopathic and aesthetic treatments, resulting in nearly complete coverage of bald areas.

In this study, a combination treatment of microinfusion (MMP®) and topical minoxidil showed a modest increase in hair density in a 28-year-old woman with chronic telogen effluvium, particularly in the parieto-vertex region, suggesting potential benefits but underscoring the need for larger trials to confirm efficacy.

This study reported that oral minoxidil improved hair density and had an acceptable safety profile in women with androgenetic alopecia.

This study found that applying a 1% BOI lotion improved hair density and thickness in patients with mild pattern hair loss over six months.